The Leadership Team at Alumis is responsible for setting the strategic direction of the company and ensuring the successful execution of its vision to transform the lives of patients with immune-mediated diseases. This team of deeply experienced professionals oversees all aspects of the company's operations, including research and development, clinical development, quality assurance, regulatory affairs, financial management, and people and culture. Their integrated approach aims to innovate and optimize targeted therapies, leveraging powerful data analytics to deliver next-generation treatments that address immune dysfunction with precision and efficacy.
Alan Colowick
Managing Director Ayurmaya, An...
Claire Langrish
Senior Vice President, Immunol...
David M Goldstein
Chief Scientific Officer
Dean Dragoli
Vice President, Medicinal Chem...
Derrick Richardson
Svp, Head Of People And Cultur...
Derrick Richardson
Senior Vice President, People ...
Grace Halteh
Vp, Head Of Quality
Grace Halteh
Vice President Of Quality
Jeff Douglas
Svp, Head Of Development Opera...
John Schroer
Chief Financial Officer
Jörn Drappa
Chief Medical Officer
Karen Pellett
Vice President, Head Of Progra...
Kolbot By
SVP Technical Operations
Mark Bradley
Chief Development Officer
Martin Babler
Chairman, President And CEO
Mera Tilley
Vp, Head Of Genetics
Michael Taylor
Vice President, Toxicology
Mike Taylor
Vp, Toxicology
Philip Nunn
Senior Vice President Preclini...
Roman Rubio
Svp, Head Of Clinical Developm...
Roy Hardiman
Chief Business And Legal Offic...
Ruixiao Lu
Vp, Head Of Biostatistics And ...
Tim Owens
Svp, Head Of Research